Amy Bachrodt, SVP, Finance at Maze Therapeutics, Inc. (MAZE), sold 10,000 shares at $38.70 ($392K) on 2026-01-02, disclosed to the SEC on 2026-01-06.
Open-market sale of $392k MAZE by SVP, Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.70 | 2,405 | $93K | 23.8% |
| 2 | $38.70 | 2,405 | $93K | 23.8% |
| 3 | $39.57 | 2,595 | $103K | 26.2% |
| 4 | $39.57 | 2,595 | $103K | 26.2% |
| Total | $39.15 avg | 10,000 | $392K | 100% |
| Filing → |
| MAZE | SELL | 2026-02-04 | $452K | — | Filing → |
| MAZE | SELL | 2026-01-26 | $455K | — | Filing → |
| MAZE | SELL | 2025-12-31 | $606K | — | Filing → |